J-Fire Multiservice Procedures for the Joint Application of Firepower: FM 90-20, MCRP 3-16.8B, NWP 3-09.2, AFTTP(I) 3-2.6.
Exclusive patent, know-how and technology license to use, manufacture, sell and sublicense modified-C-reactive protein 'mCRP' and its genetically engineered recombinant analog recombinant modified C reactive protein 'r(m)CRP', as an adjuvant to be used in human and veterinary vaccine preparations.
